Latest Anti-obesity medication Stories
Connie K. Ho for redOrbit.com Losing weight and eating healthier have gone hand-in-hand for some time. Researchers from Columbia University Medical Center (CUMC) recently discovered how to help people in their goals for weight loss; a brain receptor that was found to have abilities to help regulate appetite. The study, published in the online edition of Cell, could help create new drugs focused on combating obesity. "We've identified a receptor that is intimately involved in...
SAN DIEGO, June 6, 2012 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that the Light Study, a long-term research study of Contrave® (naltrexone SR/bupropion SR), a new, investigational drug being evaluated for weight loss, has begun enrolling patients at clinical sites throughout the United States. The Light Study is designed to assess the cardiovascular health outcomes of Contrave. To view the multimedia assets associated with this release, please...
Finding could help fight obesity epidemic Researchers at Joslin Diabetes Center have shown that while a type of "good" fat found in the body can be activated by cold temperatures, it is not able to be activated by the drug ephedrine. The finding, published in today's issue of PNAS USA Early Edition, may lead to drugs or other methods aimed at activating the good fat, known as brown fat. When activated, brown fat burns calories and can help in the battle against obesity. "We propose...
PharmaCo Labs (SupplementsToWeightLoss LLC) today announced that their non-prescription weight loss pill, PhenObestin 37.5, has been proven to help people lose weight as quickly as prescription weight-loss drugs Phentermine and Adipex. This all-natural drug is packed with cutting edge science that helped those people lose weight with no side effects. Germantown, MD (PRWEB) May 29, 2012 More than one million people from around the world have used PhenObestin 37.5 to successfully lose...
WASHINGTON, May 17, 2012 /PRNewswire/ -- JJ Smith, Nutritionist and Certified Weight-Loss Expert, offers a free eBook, "5 Reasons You Can't Lose Weight!" to those who are committed to losing weight and getting healthy in 2012! Many of the reasons for weight gain are often outside of one's control. It is important to understand the hidden causes of weight gain, such as hormonal imbalances, excess toxins, and a sluggish metabolism. When many of these hidden conditions exist,...
In the briefing documents for the May 10th, 2012 meeting of the FDA Advisory Committee, reviewers expressed concerns on safety of Lorcaserin obesity drug. Safety concerns relate mainly to heart problems. Another obesity drug, the popular Fen Phen, was withdrawn from the market in 1997. Fen Phen was linked with heart valve damage and primary pulmonary hypertension (PPH). The most insidious part of Fen Phen and heart valve damage is that many people who took Fen Phen are just now...
A panel voted 18 to 4 in favor of approving the new anti-obesity drug Lorcaserin for use on the drug market. The drug works to control the appetite through receptors in the brain, and a study showed it helped nearly half of participants lose up to five percent of their body weight. The Food and Drug Administration is scheduled to decide on June 27 whether the drug should be approved for use in the U.S. Lorcaserin was rejected by the Endocrinologic and Metabolic Drugs Advisory...
On March 29th, 2012, an FDA Advisory Panel recommended further clinical trials for weight-loss drugs to better assess heart risks. Heart risks were associated with a popular anti-obesity drug in the 1990’s, Fen Phen. The FDA pulled Fen Phen from shelves in 1997 due to concerns about heart valve damage. According to a 2008 study published in BMC Medicine, many individuals that had taken Fen Phen in the past were found to have heart valve damage up to 7 years later. Now, AttorneyOne.com, a...
The Consumer Justice Foundation, a for-profit corporation that is staffed by a team of professional consumer advocates whose mission is to provide consumers with information regarding the potential dangers of certain prescription medications via free online informational resources, hereby alerts the public of an FDA announcement that its decision regarding whether or not to approve the topiramate-containing obesity medication Qnexa will not be made on April 17. Instead, the agency will...
Despite nearly a third of Americans now being obese, as many as 70 percent say they are trying to lose weight, and many do, according to new research from researchers from Harvard Medical School and Beth Israel Deaconess Medical Center, both in Boston Mass. The researchers, reporting their findings in the American Journal of Preventive Medicine, found that most obese dieters who stuck to the tried and true methods of eating less fat, exercising more and using prescription diet pills had a...
